Portal de Periódicos da CAPES

HIV Type 1 Isolate Z321, the Strain Used to Make a Therapeutic HIV Type 1 Immunogen, Is Intersubtype Recombinant

1997; Mary Ann Liebert, Inc.; Volume: 13; Issue: 4 Linguagem: Inglês

10.1089/aid.1997.13.357

1931-8405

David Choi, Syamalima Dube, TIMOTHY P. SPICER, Herbert B. Slade, Fred C. Jensen, Bernard J. Poiesz,

Bacteriophages and microbial interactions

AIDS Research and Human RetrovirusesVol. 13, No. 4 HIV Type 1 Isolate Z321, the Strain Used to Make a Therapeutic HIV Type 1 Immunogen, Is Intersubtype RecombinantDAVID J. CHOI, SYAMALIMA DUBE, TIMOTHY P. SPICER, HERBERT B. SLADE, FRED C. JENSEN, and BERNARD J. POIESZDAVID J. CHOISearch for more papers by this author, SYAMALIMA DUBESearch for more papers by this author, TIMOTHY P. SPICERSearch for more papers by this author, HERBERT B. SLADESearch for more papers by this author, FRED C. JENSENSearch for more papers by this author, and BERNARD J. POIESZSearch for more papers by this authorPublished Online:15 Mar 2009https://doi.org/10.1089/aid.1997.13.357AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byA near full-length HIV-1 genome from 1966 recovered from formalin-fixed paraffin-embedded tissue19 May 2020 | Proceedings of the National Academy of Sciences, Vol. 117, No. 22‘Patient 0’ and the Origin of HIV/AIDS in AmericaTrends in Microbiology, Vol. 25, No. 1HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine8 June 2016 | Expert Opinion on Biological Therapy, Vol. 16, No. 7Identification of a Novel Circulating Recombinant Form (CRF) 36_cpx in Cameroon That Combines Two CRFs (01_AE and 02_AG) with Ancestral Lineages of Subtypes A and G Rebecca L.R. Powell, Jiangqin Zhao, Frank A.J. Konings, Shixing Tang, Aubin Nanfack, Sherri Burda, Mateusz M. Urbanski, D.R. Saa, Indira Hewlett, and Phillipe N. Nyambi29 August 2007 | AIDS Research and Human Retroviruses, Vol. 23, No. 8Circulating Recombinant Form (CRF) 37_cpx: An Old Strain in Cameroon Composed of Diverse, Genetically Distant Lineages of Subtypes A and G Rebecca L.R. Powell, Jiangqin Zhao, Frank A.J. Konings, Shixing Tang, Leonard Ewane, Sherri Burda, Mateusz M. Urbanski, D.R. Saa, Indira Hewlett, and Phillipe N. Nyambi3 August 2007 | AIDS Research and Human Retroviruses, Vol. 23, No. 7Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccineAIDS, Vol. 21, No. 3CD8 + T-Cell-Mediated Cross-Clade Protection in the Genital Tract following Intranasal Immunization with Inactivated Human Immunodeficiency Virus Antigen Plus CpG OligodeoxynucleotidesJournal of Virology, Vol. 79, No. 1Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNER) therapy in ThailandHIV Medicine, Vol. 5, No. 5HIV Type 1 Circulating Recombinant Form CRF09_cpx from West Africa Combines Subtypes A, F, G, and May Share Ancestors with CRF02_AG and Z321 Francine E McCutchan, Jean-Louise Sankale, Souleymane M'Boup, Bohye Kim, Sodsai Tovanabutra, Donald J. Hamel, Stephanie K. Brodine, Phyllis J. Kanki, and Deborah L. Birx25 August 2004 | AIDS Research and Human Retroviruses, Vol. 20, No. 8Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjectsVaccine, Vol. 22, No. 23-24The evolution of HIV and its consequencesInfectious Disease Clinics of North America, Vol. 18, No. 2HIV Type 1 Antigen-Responsive CD4+ T-Lymphocytes in Exposed Yet HIV Type 1 Seronegative Ugandans Anthony Kebba, Pontiano Kaleebu, Jennifer Serwanga, Samantha Rowland, David Yirrell, Robert Downing, Jill Gilmour, Nesrina Imami, Frances Gotch, and Jimmy Whitworth5 July 2004 | AIDS Research and Human Retroviruses, Vol. 20, No. 1HIV-specific immunity during structured antiviral drug treatment interruptionVaccine, Vol. 21, No. 11-12Analysis of Partial pol and env Sequences Indicates a High Prevalence of HIV Type 1 Recombinant Strains Circulating in Gabon Ivona Pandrea, David L. Robertson, Richard Onanga, Feng Gao, Maria Makuwa, Paul Ngari, Issa Bedjabaga, Pierre Roques, François Simon, and Cristian Apetrei5 July 2004 | AIDS Research and Human Retroviruses, Vol. 18, No. 15Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent modelImmunology, Vol. 106, No. 4Generation of Th1 immune responses to inactivated, gp120-depleted HIV-1 in mice with a dominant Th2 biased immune profile via imunostimulatory oligonucleotides—relevance to AIDS vaccines in developing countriesVaccine, Vol. 20, No. 21-22Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination2 May 2002 | Clinical and Experimental Immunology, Vol. 128, No. 2Long-Term Follow-Up of HIV-1–Infected Thai Patients Immunized with Remune Monotherapy2 February 2015 | HIV Clinical Trials, Vol. 2, No. 5Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution29 June 2001 | Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, Vol. 356, No. 1410Expression of perforin on HIV-1-specific CD8 + lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen12 January 2002 | Clinical & Experimental Immunology, Vol. 124, No. 2A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West AfricaJournal of General Virology, Vol. 82, No. 5The effects of an HIV-1 immunogen (Remune) on viral load, CD4 cell counts and HIV-specific immunity in a double-blind, randomized, adjuvant-controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs20 December 2001 | HIV Medicine, Vol. 2, No. 2Identification of a Complex env Subtype E HIV Type 1 Virus from the Democratic Republic of Congo, Recombinant with A, G, H, J, K, and Unknown Subtypes Nicole Vidal, Claire Mulanga-Kabeya, Nzila Nzilambi, Eric Delaporte, and Martine Peeters5 July 2004 | AIDS Research and Human Retroviruses, Vol. 16, No. 18HIV-Specific CD4+ and CD8+ Immune Responses Are Generated with a gp120-Depleted, Whole-Killed HIV-1 Immunogen with CpG Immunostimulatory Sequences of DNA Ronald B. Moss, Jocelyn Diveley, Fred C. Jensen, Erin Gouveia, Jay Savary, and Dennis J. Carlo7 July 2004 | Journal of Interferon & Cytokine Research, Vol. 20, No. 12Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central AfricaJournal of Virology, Vol. 74, No. 22Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogenAIDS, Vol. 14, No. 16T-Helper-Cell Proliferative Responses to Whole-Killed Human Immunodeficiency Virus Type 1 (HIV-1) and p24 Antigens of Different Clades in HIV-1-Infected Subjects Vaccinated with HIV-1 Immunogen (Remune)Clinical Diagnostic Laboratory Immunology, Vol. 7, No. 5A Double-Blind, Adjuvant-Controlled Trial of Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen (Remune) Monotherapy in Asymptomatic, HIV-1-Infected Thai Subjects with CD4-Cell Counts of >300Clinical Diagnostic Laboratory Immunology, Vol. 7, No. 5Molecular Characterization of a Recombinant HIV Type 1 Isolate (A/G/E/?): Unidentified Regions May Be Derived from Parental Subtype E Sequences D. Paraskevis, M. Magiorkinis, V. Paparizos, G. N. Pavlakis, and A. Hatzakis5 July 2004 | AIDS Research and Human Retroviruses, Vol. 16, No. 9Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen Vernon C. Maino, Maria A. Suni, Susan B. Wormsley, Dennis J. Carlo, M Ark R. Wallace, and Ronald B. Moss5 July 2004 | AIDS Research and Human Retroviruses, Vol. 16, No. 6Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in AfricaMicrobiology, Vol. 81, No. 2Presence of Multiple HIV Subtypes and a High Frequency of Subtype Chimeric Viruses in Heterosexually Infected WomenJournal of Acquired Immune Deficiency Syndromes, Vol. 22, No. 4Presence of Multiple HIV Subtypes and a High Frequency of Subtype Chimeric Viruses in Heterosexually Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 22, No. 4Cell-associated HIV-1 messenger RNA and DNA in T-helper cell and monocytes in asymptomatic HIV-1-infected subjects on HAART plus an inactivated HIV-1 immunogenAIDS, Vol. 13, No. 13Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc4218 August 1999 | Oncogene, Vol. 18, No. 33An Isolate of Human Immunodeficiency Virus Type 1 Originally Classified as Subtype I Represents a Complex Mosaic Comprising Three Different Group M Subtypes (A, G, and I)Journal of Virology, Vol. 72, No. 12Sequence Note: A Novel Subtype A/G/J Recombinant Full-Length HIV Type 1 Genome from Burkina Faso ROBERT B. OELRICHS, CASSY WORKMAN, TIINA LAUKKANEN, FRANCINE E. McCUTCHAN, and NICHOLAS J. DEACON15 March 2009 | AIDS Research and Human Retroviruses, Vol. 14, No. 16Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in ThailandAIDS, Vol. 12, No. 12Full Genome Sequences of Human Immunodeficiency Virus Type 1 Subtypes G and A/G Intersubtype RecombinantsVirology, Vol. 247, No. 1gag and env Sequences of an A/G/H Recombinant from a Zairian HIV Type 1 Isolate SANDRINE DUCHET, FRANCK LETOURNEUR, IBTISSAM LOUSSERT-AJAKA, CHANTAL CHAPLAIN, EMMANUEL GOMAS, FRANÇOISE BRUN-VEZINET, FRANÇOIS SIMON, and SENTOB SARAGOSTI15 March 2009 | AIDS Research and Human Retroviruses, Vol. 13, No. 15Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, Remune™) in Human Immunodeficiency Virus Type-1 Seropositive Subjects RONALD B. MOSS, WIESLAWA GIERMAKOWSKA, PAOLA LANZA, JOHN L. TURNER, MARK R. WALLACE, FRED C. JENSEN, GEORGIA THEOFAN, STEVEN P. RICHIERI, and DENNIS J. CARLO29 January 2009 | Viral Immunology, Vol. 10, No. 4 Volume 13Issue 4Mar 1997 To cite this article:DAVID J. CHOI, SYAMALIMA DUBE, TIMOTHY P. SPICER, HERBERT B. SLADE, FRED C. JENSEN, and BERNARD J. POIESZ.HIV Type 1 Isolate Z321, the Strain Used to Make a Therapeutic HIV Type 1 Immunogen, Is Intersubtype Recombinant.AIDS Research and Human Retroviruses.Mar 1997.357-361.http://doi.org/10.1089/aid.1997.13.357Published in Volume: 13 Issue 4: March 15, 2009PDF download